Related Experiment Video
Updated: Aug 11, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
[Inhibitory effects of RNA interference on MMP-24 expression and invasiveness of ovarian cancer SKOV(3) cells]
Ya-ping Luo1, Mei Zhong, Li-ping Wang
1Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. lyp76700@163.com
Objective:
To investigate the inhibitory effect of RNA interference (RNAi) on MMP-24 expression and invasiveness of ovarian cancer SKOV(3) cells.
Method:
Two pairs of small interfering RNA (siRNA) specific to MMP-24 mRNA were designed and transfected into SKOV(3) cells. RT-PCR and Western blotting were used to detect the mRNA and protein expressions of MMP-24, and the cell invasiveness was assessed using an in vitro invasion test.
Results:
After transfection with siRNA, the mRNA and protein expression levels of MMP-24 were obviously reduced in SKOV(3) cells, which also showed significantly decreased invasiveness in vitro.
Conclusions:
MMP-24 gene silencing by RNAi can suppress the invasiveness of ovarian cancer SKOV(3) cells in vitro, which may provide a new therapeutic approach of ovarian cancer.
Insights
RNA interference effectively reduced matrix metalloproteinase-24 (MMP-24) expression in ovarian cancer cells. This gene silencing suppressed cancer cell invasiveness, suggesting a potential new therapy for ovarian cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Context:
- Ovarian cancer is a leading cause of cancer-related deaths in women.
- Matrix metalloproteinase-24 (MMP-24) is implicated in cancer progression and invasion.
- Developing targeted therapies to inhibit cancer cell invasiveness is crucial.
Purpose:
- To investigate the efficacy of RNA interference (RNAi) in suppressing MMP-24 expression.
- To evaluate the impact of MMP-24 inhibition on the invasiveness of SKOV(3) ovarian cancer cells.
- To explore RNAi targeting MMP-24 as a potential therapeutic strategy for ovarian cancer.
Summary:
- Small interfering RNA (siRNA) targeting MMP-24 mRNA was designed and transfected into SKOV(3) cells.
- RT-PCR and Western blotting confirmed significant reduction in MMP-24 mRNA and protein levels.
- In vitro invasion assays demonstrated a marked decrease in the invasiveness of SKOV(3) cells post-transfection.
Impact:
- MMP-24 gene silencing via RNAi effectively inhibits ovarian cancer cell invasiveness.
- This study provides a foundation for developing novel RNAi-based therapeutic approaches for ovarian cancer.
- Targeting MMP-24 represents a promising strategy to combat ovarian cancer progression and metastasis.
More Related Videos
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Inhibitors of Viral Protein Synthesis

